Preclinical Safety
Master essential principles of drug safety evaluation, including toxicology studies, risk assessment, and clinical trial safety considerations.
Master essential principles of drug safety evaluation, including toxicology studies, risk assessment, and clinical trial safety considerations.
This course cannot be purchased separately - to access the complete learning experience, graded assignments, and earn certificates, you'll need to enroll in the full Drug Hunting: The Science of Making New Medicines Specialization program. You can audit this specific course for free to explore the content, which includes access to course materials and lectures. This allows you to learn at your own pace without any financial commitment.
5
(13 ratings)
3,727 already enrolled
Instructors:
English
Powered by
What you'll learn
Understand toxicology's role in drug development
Master preclinical safety testing methodologies
Learn risk assessment and therapeutic index calculation
Apply safety considerations for human dose selection
Evaluate clinical trial safety requirements
Skills you'll gain
This course includes:
1 Hours PreRecorded video
7 quizzes, 3 assignments
Access on Mobile, Tablet, Desktop
FullTime access
Shareable certificate
Closed caption
Top companies offer this course to their employees
Top companies provide this course to enhance their employees' skills, ensuring they excel in handling complex projects and drive organizational success.
There are 3 modules in this course
This comprehensive course explores the critical aspects of preclinical safety in drug development. Students learn about toxicology principles, safety testing methodologies, and risk assessment strategies. The curriculum covers in vitro and in vivo toxicology studies, therapeutic index calculation, and safety considerations for human clinical trials. Through expert instruction, learners understand how safety data guides human dose selection and clinical development decisions.
Preclinical Safety, part 1
Module 1 · 2 Hours to complete
Preclinical Safety, part 2
Module 2 · 1 Hours to complete
Preclinical Safety, part 3
Module 3 · 2 Hours to complete
Fee Structure
Instructors
7 Courses
Medicinal Chemistry Expert and Educator at Davidson College
Dr. Erland Stevens is a distinguished faculty member in the Chemistry department at Davidson College, bringing a wealth of experience in medicinal chemistry and drug discovery to his role. After earning his Ph.D. from the University of Michigan at Ann Arbor in 1997, specializing in nitrogen heterocycles under Will Pearson, Stevens pursued postdoctoral studies at The Scripps Research Institute with K. Barry Sharpless. Joining Davidson College in 1998, he has since become a cornerstone of the chemistry program, regularly teaching medicinal chemistry to junior and senior undergraduates. Stevens' expertise extends beyond academia, as evidenced by his involvement in the continuing education program at GlaxoSmithKline's Research Triangle Park site in 2006 and 2007. His contributions to the field include authoring the textbook "Medicinal Chemistry: The Modern Drug Discovery Process," published by Pearson Education, which has likely become a valuable resource for students and professionals in the field. Stevens' research focuses on the synthesis and activity of antiviral nucleoside analogues, demonstrating his ongoing commitment to advancing pharmaceutical science. His career exemplifies the integration of academic research, industry relevance, and dedicated teaching in the field of medicinal chemistry.
Director of Preclinical Safety at Novartis
Dr. Alan P. Brown is a Director in Preclinical Safety at Novartis, where he supports therapeutic programs focused on cardiovascular disease. His responsibilities include evaluating compounds for in-licensing and acquisitions, co-chairing a liver safety advisory team, and conducting educational workshops for colleagues at Novartis. Dr. Brown holds a Bachelor of Science in microbiology from the University of Michigan and a Ph.D. in pharmacology and toxicology from the University of Arizona. He completed postdoctoral research at Michigan State University and is a Diplomate of the American Board of Toxicology. With extensive experience in the pharmaceutical industry, he plays a vital role in ensuring the safety and efficacy of new therapeutic compounds.
Testimonials
Testimonials and success stories are a testament to the quality of this program and its impact on your career and learning journey. Be the first to help others make an informed decision by sharing your review of the course.
5 course rating
13 ratings
Frequently asked questions
Below are some of the most commonly asked questions about this course. We aim to provide clear and concise answers to help you better understand the course content, structure, and any other relevant information. If you have any additional questions or if your question is not listed here, please don't hesitate to reach out to our support team for further assistance.